Look jonny, may i call you jonny. What you are obviously missing is that I am trying to give the stock a shameless plug because I am long out my ass...........and then you come in saying "(doesn't sound like a cure)?" Who the $**&%&* are you? IT IS A CURE GODDAMMIT!
It's hard to say it's a cure and they don't even say that. It modifys existing T-Cells, but the stem line will still produce T-Cells without the disrupted gene, thereby requiring continuous (and profitable) treatment. Unless it enables the body to completely clear the virus,you can't call it a cure. But it sounds great, as it appears to have the potential to to allow the body to suppress the virus so that the individual is healthy and non-contagious. This approach might lend itself toother therapies against other viruses, which, like the HIV, need a portal of entry into a human cell. I wonder if this company can patent not just the new enzyme, but the whole works and sew up the general therapuetic approach.